Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Title Xponential Fitness Q4 Earnings Report Insights for Investors

Elaine Mendonca by Elaine Mendonca
March 1, 2024
in Breaking News
0
Fitness and app
0
SHARES
7
VIEWS
Share on FacebookShare on Twitter

Xponential Fitness, a leading fitness company, unveiled its Q4 earnings on February 29, 2024, providing valuable insights for investors. Surprisingly, the company fell short of estimated earnings by a significant -47.0%, reporting an EPS of $0.08 compared to the anticipated $0.15. Despite this, revenue saw a notable increase of $18.93 million from the same period the previous year.

Reflecting on past performance, Xponential Fitness also missed EPS in the previous quarter by $0.04, resulting in a 7.000000000000001% decline in share price the following day. Here is a summary of the company’s performance in various quarters:
– Q3 2023: EPS Estimate 0.15, EPS Actual 0.11, Revenue Estimate 74.68M, Revenue Actual 80.44M
– Q2 2023: EPS Estimate 0.11, EPS Actual 0.07, Revenue Estimate 71.93M, Revenue Actual 77.34M
– Q1 2023: EPS Estimate 0.13, EPS Actual -0.02, Revenue Estimate 65.45M, Revenue Actual 70.69M
– Q4 2022: EPS Estimate 0.10, EPS Actual 0.11, Revenue Estimate 66.74M, Revenue Actual 71.27M.

Investors seeking more in-depth financial information and updates on Xponential Fitness’s earnings releases and performance can explore their investor relations website.

XPOF Stock Price Update: February 29, 2024 – Is the Upward Momentum Sustainable?

On February 29, 2024, XPOF stock closed at $10.08, marking a $0.34 increase from the previous market close, representing a 3.49% rise in the stock price. In after-hours trading, the stock continued to climb, rising a further $0.33. Despite this positive movement, XPOF is currently trading near the bottom of its 52-week range and below its 200-day simple moving average, suggesting recent challenges. Investors may be watching XPOF to see if this upward momentum can be sustained. Conducting research before making investment decisions is important, as market conditions can change rapidly.

XPOF Stock Performance Analysis: Revenue Growth, Net Income Decline, and EPS Fluctuation – February 29, 2024

XPOF stock had a mixed performance on February 29, 2024, as the company reported its financial results for the past year and the third quarter. According to data from CNN Money, XPOF’s total revenue stood at $244.95 million for the past year, representing a 57.95% increase compared to the previous year. However, the total revenue for the third quarter was $80.44 million, showing a 4.0% increase compared to the previous quarter. XPOF’s net income for the past year was $22.16 million, which was a 17.86% decrease compared to the previous year. The net income for the third quarter was -$20.16 million, indicating a significant decrease of 632.74% compared to the previous quarter. In terms of earnings per share (EPS), XPOF reported a figure of -$0.87 for the past year, which was a 67.36% increase compared to the previous year. However, the EPS for the third quarter was -$0.50, showing a decrease of 143.91% compared to the previous quarter. Overall, XPOF’s stock performance on February 29, 2024, reflects a mixed picture with revenue showing strong growth but net income and EPS experiencing significant declines. Investors may need to closely monitor the company’s financial performance and outlook to make informed decisions about their investment in XPOF stock.

Tags: XPOF
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Finance_Capitalization

Analyzing Organogenesis Holdings Incs Q4 Earnings Performance

Finance_Accounting (2)

Elastic Corporations Q3 Financial Report Surprising Stock Drop Despite Exceeding Expectations

Biotechnology Stock Bull Market

Organogenesis Holdings Inc Reports Decline in Net Revenue for Q4 2023 Focuses on Growth Strategies for 2024

Recommended

Torrid Holdings Stock

Torrid Holdings Faces Critical Earnings Test

5 months ago
Take-Two Stock

Take-Two Shares in Holding Pattern as Investors Await GTA VI Details

6 months ago
Union Pacific Stock

Union Pacific’s Future Hangs in Balance as Historic Railroad Merger Faces Critical Vote

4 months ago
Biotechnology Markets and money

BioTechnes Quarterly Earnings and Stock Performance Analysis

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Graftech Shares Plunge on Bleak Quarterly Results

Potbelly Accelerates Northeast Growth with New Jersey Franchise Push

Conduent Faces Mounting Fallout from Major Data Breach Ahead of Earnings

Blue Ridge Bankshares Emerges from Regulatory Challenges with Return to Profitability

Navigating the Interest Rate Tightrope: Bank7’s Path Forward

Claros Mortgage Trust Secures Financial Flexibility Through Strategic Debt Overhaul

Trending

Vigil Neuroscience Stock
Healthcare

Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy

by SiterGedge
February 7, 2026
0

The integration of Vigil Neuroscience into French pharmaceutical giant Sanofi has been finalized. This strategic move, which...

Repay Holdings Stock

Repay Holdings: Annual Report to Test Strategic Refinancing Success

February 7, 2026
Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

February 7, 2026
Graftech Stock

Graftech Shares Plunge on Bleak Quarterly Results

February 7, 2026
Potbelly Stock

Potbelly Accelerates Northeast Growth with New Jersey Franchise Push

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy
  • Repay Holdings: Annual Report to Test Strategic Refinancing Success
  • Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com